JAK2 V617F-mutated polycythemia vera developing in a patient with a 20-year-long chronic myeloid leukemia at the time of first molecular response-Reference-Cited by-同舟云学术

JAK2 V617F-mutated polycythemia vera developing in a patient with a 20-year-long chronic myeloid leukemia at the time of first molecular response

Published:2023-03-22 Issue:5 Volume:102 Page:1279-1280
ISSN:0939-5555
Container-title:Annals of Hematology
language:en
Short-container-title:Ann Hematol

Author:

Tosoni Luca,Fabbro Dora,Pizzano Umberto,Mullai Rikard,Morelli Gianluca,Franzoni Alessandra,Damante Giuseppe,Toffoletti Eleonora,Damiani Daniela,Fanin Renato,Tiribelli Mario^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Hematology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00277-023-05187-5.pdf

Reference10 articles.

1. Nangalia J, Green AR (2017) Myeloproliferative neoplasms: from origins to outcomes. Blood 130:2475–2483

2. Krämer A, Reiter A, Kruth J, Erben P, Hochhaus A, Müller M, Cross NCP, Jones AV, Ho AD, Hensel M (2007) JAK2-V617F mutation in a patient with Philadelphia-chromosome-positive chronic myeloid leukaemia. Lancet Oncol 8:658–660

3. Kim Y-K, Shin M-G, Kim H-R, Yang D-H, Cho S-H, Lee J-J, Chung I-J, Ryang D-W, Kim H-J (2008) Simultaneous occurrence of the JAK2V617F mutation and BCR-ABL gene rearrangement in patients with chronic myeloproliferative disorders. Leuk Res 32:903–1003

4. Pardini S, Fozza C, Contini S, Rimini E, Ottaviani E, Amabile M, Rosti G, Longinotti M (2008) A case of coexistence between JAK2V617F and BCR/ABL. Eur J Haematol 81:75–76

5. Yamada O, Mahfoudhi E, Plo I, Ozaki K, Nakatake M, Akiyama M, Yamada H, Kawauchi K, Vainchenker W (2014) Emergence of a BCR-ABL translocation in a patient with the JAK2V617F mutation: evidence for secondary acquisition of BCR-ABL in the JAK2V617F clone. J Clin Oncol 32:e76–e79

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Co-occurrence of JAK2-V617 F mutation and BCR::ABL1 translocation in chronic myeloproliferative neoplasms: a potentially confounding genetic combination;Frontiers in Oncology;2024-01-12

2. Bosutinib;Reactions Weekly;2023-10-28

3. Comment on: JAK2 V617F-mutated polycythemia vera developing in a patient with a 20-year-long chronic myeloid leukemia at the time of first molecular response;Annals of Hematology;2023-05-31